Research protocols often coordinate injection timing to align both compounds pulsatile signals GHRPs producing acute GH release, GHRH analogs supporting sustained pituitary responsiveness
For 5 mg Vials: Peptide Vials (8 weeks): 23 vials (112 mg total) Peptide Vials (12 weeks): 34 vials (168 mg total) Peptide Vials (16 weeks): 45 vials (224 mg total) Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial For 10 mg Vials: Peptide Vials (8 weeks): 11 vials (105 mg total) Peptide Vials (12 weeks): 17 vials (161 mg total) Peptide Vials (16 weeks): 22 vials (217 mg total) Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial For 20 mg Vials: Peptide Vials (8 weeks): 6 vials (105 mg total) Peptide Vials (12 weeks): 9 vials (161 mg total) Peptide Vials (16 weeks): 11 vials (217 mg total) Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial Common Supplies for All Protocols: Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day) 8 weeks: 56 syringes , 12 weeks: 84 syringes , 16 weeks: 112 syringes Alcohol Swabs: Per week: 14 swabs (2/day) 8 weeks: 112 swabs , 12 weeks: 168 swabs , 16 weeks: 224 swabs Protocol Overview Concise summary of the FDA-approved once-daily regimen
For an FDA-approved GHRH analog, tesamorelin is the closest comparison
H., Kroll, A
The cost-per-measurable-result calculation often favors the stack because the clinical effects are larger and more reliable, but patients on tight budgets sometimes default to Sermorelin for the lower headline cost
Based on this assessment, we recommend the most appropriate IV drip and frequency to help you achieve optimal wellness
